Episode 409: AUA 2025 – CREST – BCG +/- Sasanlimab in High-Risk NMIBC | GU Oncology Now
Dr. Neal Shore joins the show to discuss exciting data from the CREST trial at the American Urological Association Annual Meeting.
Dr. Neal Shore joins the show to discuss exciting data from the CREST trial at the American Urological Association Annual Meeting.
Struggling to get or maintain an erection might seem like a problem limited to the bedroom, but for many men, it goes deeper. Erectile dysfunction…
Is it so hard to change your diet to one that favors health and vitality? Not really. The ideas and suggestions here are easy to…
Find lung cancer news and updates from the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30, in Chicago, Illinois.
A new study published in the journal Medicine & Science in Sports & Exercise has found that there are no differences in rates of muscle…
The study involved 40 participants who were fed either a vegan or omnivorous diet and asked to complete 3 sessions of whole-body resistance training over…
Researchers have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment
SIRT2, an enzyme previously overlooked in astrocytic GABA production, may be crucial for distinguishing the specific effects of degenerative molecules involved in Alzheimer’s disease. A…
Tom Powles: Podcast with Neal Shore around the CREST RIII untreated NMIBC BCG +/- PD1 trial / cancer, CREST RIII, fight against cancer, Global fight…
Read the latest research and news curated for heme today videos.
A recent study presented at AUA 2025 sought to evaluate the efficacy of [68Ga]-FAPI-PET imaging for the loco-regional staging of patients with muscle-invasive bladder cancer.